Enzo Biochem Inc (ENZ)
1.06
-0.03
(-2.75%)
USD |
NYSE |
Apr 24, 16:00
1.065
0.00 (0.00%)
After-Hours: 20:00
Enzo Biochem Net Income (Quarterly): -3.061M for Jan. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -3.061M |
| October 31, 2023 | -6.616M |
| July 31, 2023 | 57.43M |
| April 30, 2023 | -15.19M |
| January 31, 2023 | -11.32M |
| October 31, 2022 | -10.64M |
| July 31, 2022 | -8.433M |
| April 30, 2022 | -4.854M |
| January 31, 2022 | -2.655M |
| October 31, 2021 | -2.319M |
| July 31, 2021 | 3.268M |
| April 30, 2021 | 2.006M |
| January 31, 2021 | 2.302M |
| October 31, 2020 | 0.299M |
| July 31, 2020 | -3.325M |
| April 30, 2020 | -9.86M |
| January 31, 2020 | -7.687M |
| October 31, 2019 | -7.648M |
| July 31, 2019 | -5.387M |
| April 30, 2019 | 22.26M |
| January 31, 2019 | -8.408M |
| October 31, 2018 | -5.981M |
| July 31, 2018 | -5.764M |
| April 30, 2018 | -3.016M |
| January 31, 2018 | -0.901M |
| Date | Value |
|---|---|
| October 31, 2017 | -0.64M |
| July 31, 2017 | 0.094M |
| April 30, 2017 | -0.071M |
| January 31, 2017 | -1.053M |
| October 31, 2016 | -1.474M |
| July 31, 2016 | 36.14M |
| April 30, 2016 | -2.115M |
| January 31, 2016 | 6.832M |
| October 31, 2015 | 4.434M |
| July 31, 2015 | 8.442M |
| April 30, 2015 | -2.907M |
| January 31, 2015 | -4.091M |
| October 31, 2014 | -3.729M |
| July 31, 2014 | -3.169M |
| April 30, 2014 | -0.455M |
| January 31, 2014 | -3.566M |
| October 31, 2013 | -2.787M |
| July 31, 2013 | -3.102M |
| April 30, 2013 | -5.77M |
| January 31, 2013 | -5.674M |
| October 31, 2012 | -3.691M |
| July 31, 2012 | -27.14M |
| April 30, 2012 | -3.411M |
| January 31, 2012 | -4.221M |
| October 31, 2011 | -4.494M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.19M
Minimum
Apr 2023
57.43M
Maximum
Jul 2023
-0.5708M
Average
-4.090M
Median
Net Income (Quarterly) Benchmarks
| Delcath Systems Inc | -11.14M |
| Star Equity Holdings Inc | 1.728M |
| Exact Sciences Corp | -49.77M |
| CytoSorbents Corp | -5.835M |
| Progyny Inc | 13.47M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.553M |
| Total Expenses (Quarterly) | 9.977M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | -0.871M |
| Gross Profit Margin (Quarterly) | 49.39% |
| Profit Margin (Quarterly) | -35.79% |
| Earnings Yield | 62.91% |
| Normalized Earnings Yield | -6.829 |